Microinflammation is a common risk factor for progression of nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 88, Issue 2, 2010, Pages 171-176

  Kajitani, Nobuo ^a   Shikata, Kenichi ^a   Nakamura, Akihiko ^b   Nakatou, Tatsuaki ^c   Hiramatsu, Makoto ^c   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Department of Internal Medicine   (Japan)

^c OKAYAMA SAISEIKAI GENERAL HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Diabetic nephropathy; IP 10; Microinflammation; TNF

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RISK FACTOR; URINARY EXCRETION;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; JAPAN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 77952885872     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.01.012     Document Type: Article

References (29)

1. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
2. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 2004, 351:2599-2610.
3. de Jager J., Dekker J.M., Kooy A., Kostense P.J., Nijpels G., Heine R.J., et al. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn study. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1086-1093.
4. Wang X., Yue T.L., Ohlstein E.H., Sung C.P., Feuerstein G.Z. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J. Biol. Chem. 1996, 271:24286-24293.
5. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int. 2000, 58:1703-1710.
6. Pickup J.C., Chusney G.D., Thomas S.M., Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci. 2000, 67:291-300.
7. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 2000, 102:42-47.
8. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
9. Arnalich F., Hernanz A., Lopez-Maderuelo D., Pena J.M., Camacho J., Madero R., et al. Enhanced acutephase response and oxidative stress in older adults with type II diabetes. Horm. Metab. Res. 2000, 32:407-412.
10. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
11. Hirata K., Shikata K., Matsuda M., Akiyama K., Sugimoto H., Kushiro M., et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia 1998, 41:185-192.
12. Sugimoto H., Shikata K., Hirata K., Akiyama K., Matsuda M., Kushiro M., et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 1997, 46:2075-2081.
13. Albertini J.P., Valensi P., Lormeau B., Aurousseau M.H., Ferrière F., Attali J.R., et al. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care 1998, 21:1008-1013.
14. Okada S., Shikata K., Matsuda M., Ogawa D., Usui H., Kido Y., et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003, 52:2586-2593.
15. Nakamura A., Shikata K., Hiramatsu M., Nakatou T., Kitamura T., Wada J., et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes. Diabetes Care 2005, 28:2890-2985.
16. Bruno G., Cavallo-Perin P., Bargero G., Borra M., D'Errico N., Pagano G. Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann. Intern. Med. 1996, 125:653-657.
17. Mykkanen L., Zaccaro D., O'Leary D., Howard G., Robbins D., Haffner S. Microalbuminuria and carotid artery intimamedia thickness in nondiabetic and NIDDM subjects: the insulin resistance atherosclerosis study (IRAS). Stroke 1997, 28:1710-1716.
18. Yokoyama H., Aoki T., Imahori M., Kuramitsu M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int. 2004, 66:448-454.
19. Navarro J.F., Mora C., Gómez M., Muros M., López-Aguilar C., García J. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Nephrol. Dial. Transplant. 2008, 23:919-926.
20. Mine S., Okada Y., Tanikawa T., Kawahara C., Tabata T., Tanaka Y. Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 2006, 344:780-785.
21. Kiyici S., Erturk E., Budak F., Ersoy C., Tuncel E., Duran C., et al. Serum monocyte chemoattractant protein-1 and monocyte adhesion molecules in type 1 diabetic patients with nephropathy. Arch. Med. Res. 2006, 37:998-1003.
22. O'Mahony L., Holland J., Jackson J., Feighery C., Hennessy T.P., Mealy K. Quantitative intracellular cytokine measurement: age-related changes in proinflammatory cytokine production. Clin. Exp. Immunol. 1998, 113:213-219.
23. Picchi A., Gao X., Belmadani S., Potter B.J., Focardi M., Chilian W.M., et al. Tumor necrosis factor-α induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ. Res. 2006, 99:69-77.
24. Sugimoto H., Shikata K., Wada J., Horiuchi S., Makino H. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 1999, 42:878-886.
25. Moriwaki Y., Yamamoto T., Shibutani Y., Aoki E., Tsutsumi Z., Takahashi S., et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 2003, 52:605-608.
26. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 1999, 104:1041-1050.
27. Schmid H., Boucherot A., Yasuda Y., Henger A., Brunner B., Eichinger F., et al. European Renal cDNA Bank (ERCB) Consortium. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006, 55:2993-3003.
28. Tang W.W., Qi M., Warren J.S., Van G.Y. Chemokine expression in experimental tubulointerstitial nephritis. J. Immunol. 1997, 159:870-876.
29. Bonacchi A., Romagnani P., Romanelli R.G., Efsen E., Annunziato F., Lasagni L., et al. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J. Biol. Chem. 2001, 276:9945-9954.